Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations with Treatment Resistance in Clear Cell and Nonclear Cell Tumors. Journal of Kidney Cancer, [S. l.], v. 12, n. 2, p. 37–45, 2025. DOI: 10.15586/jkcvhl.v12i2.386. Disponível em: https://jkcvhl.com/~jkcvhlco/index.php/jkcvhl/article/view/386. Acesso em: 17 apr. 2026.